Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations

Acta Neurologica Scandinavica

Volumn 119, Issue 5, 2009, Pages 313-320

  Ahlgren, Cecilia ^a   Oden A ^b   Toren K ^a   Andersen, O ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Infections; Multiple sclerosis; Neuroepidemiology

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; MULTIPLE SCLEROSIS; PUBLIC HEALTH; SCHOOL CHILD; VACCINATION; VIRUS INFECTION;

AGE DISTRIBUTION; COHORT STUDIES; COMORBIDITY; INCIDENCE; MEASLES; MEASLES-MUMPS-RUBELLA VACCINE; MULTIPLE SCLEROSIS; MUMPS; PROPORTIONAL HAZARDS MODELS; RISK REDUCTION BEHAVIOR; RUBELLA; SEX DISTRIBUTION; SWEDEN;

EID: 64549094675     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2008.01131.x     Document Type: Article

References (38)

1. Compston DA, Vakarelis BN, Paul E, Mcdonald WI, Batchelor JR, Mims CA. Viral infection in patients with multiple sclerosis and HLA-DR matched controls. Brain 1986 2 : 325 44.
2. Granieri E, Casetta I. Selected reviews common childhood and adolescent infections and multiple sclerosis. Neurology 1997 2 (Suppl. 2 S42 54.
3. Sundstrom P, Juto P, Wadell G et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 2004 62 : 2277 82.
4. Owens GP, Bennett JL, Gilden DH, Burgoon MP. The B cell response in multiple sclerosis. Neurol Res 2006 28 : 236 44.
5. Hafler DA, Compston A, Sawcer S et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007 357 : 851 62.
6. Bjorvatn B, Skoldenberg B. [Meningitis in mumps and orchitis in Stockholm during 1955-1976 - an epidemiological background for a vaccination policy] Swedish. Lakartidningen 1978 75 : 2295 8.
7. Christenson B, Bottiger M. Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule. Vaccine 1991 9 : 326 9.
8. Taranger J. Vaccination programme for eradication of measles, mumps, and rubella. Lancet 1982 1 : 915 6.
9. Bottiger M, Christenson B, Romanus V, Taranger J, Strandell A. Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella. Br Med J (Clin Res Ed) 1987 295 : 1264 7.
10. Statistics Sweden. Total Population Register (TPR), Sweden : Statistics Sweden. Available at: http://www.scb.se.
11. Svenningsson A, Runmarker B, Lycke J, Andersen O. Incidence of MS during two fifteen-year periods in the Gothenburg region of Sweden. Acta Neurol Scand 1990 82 : 161 8.
12. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 13 : 227 31.
13. Brex PA, Ciccarelli O, O'riordan JI, Sailer M, Thompson AJ, Miller DH. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002 346 : 158 64.
14. Ahlgren C, Taranger J, Johansson L, Andersen O. Elimination of childhood diseases: possible influence on the incidence of multiple sclerosis soon detectable. Neuroepidemiology 2002 21 : 306 9.
15. Mcdonald WI, Compston A, Edan G et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 50 : 121 7.
16. Barkhof F, Filippi M, Miller DH et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997 120 : 2059 69.
17. Tintore M, Rovira A, Martinez MJ et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 2000 21 : 702 6.
18. Strom J. Social development and declining incidence of some common epidemic diseases in children. A study of the incidence in different age groups in Stockholm. Acta Paediatr Scand 1967 56 : 159 63.
19. Strom J. [On the incidence of common epidemics of infectious diseases in the light of conditions in Stockholm.] Swedish. Soc Med Tidskr 1959 36 : 347 54.
20. Lundstrom R, Svedmyr A, Hagbard L, Kaijser K. Rubella immunity as related to age and history of overt disease. Acta Paediatr Scand 1967 56 : 279 85.
21. Bottiger M, Heller L, Rollof SI. [Rubella vaccination of teen-age girls] Swedish. Lakartidningen 1974 71 : 1949 51.
22. Taranger J. Swedish. Lakartidningen 1982 79 : 3430 1.
23. Bottiger M, Forsgren M. Twenty years' experience of rubella vaccination in Sweden: 10 years of selective vaccination (of 12-year-old girls and of women postpartum) and 13 years of a general two-dose vaccination. Vaccine 1997 15 : 1538 44.
24. Lehmann EL. Testing statistical hypotheses 2 edn. Pacific Grove, CA : Wadsworth & Brooks/Cole Advanced Books & Software, 1991.
25. Breslow NE. Statistical methods in cancer research. The design and analysis of cohort studies. Vol. 2, The design and analysis of cohort studies. Lyon : International Agency for Research on Cancer, 1987.
26. Bansil S, Troiano R, Dowling PC, Cook SD. Measles vaccination does not prevent multiple sclerosis. Neuroepidemiology 1990 9 : 248 54.
27. Currier RD, Meydrech EF, Currier MM. Measles vaccination has had no effect on the occurrence of multiple sclerosis. Arch Neurol 1996 53 : 1216.
28. Destefano F, Verstraeten T, Jackson LA et al. Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol 2003 60 : 504 9.
29. Eurodiab Substudy 2 Study Group. Infections and vaccinations as risk factors for childhood type I (insulin-dependent) diabetes mellitus: a multicentre case-control investigation. EURODIAB Substudy 2 Study Group. Diabetologia 2000 43 : 47 53.
30. Mckenna MJ. Differences in vitamin D status between countries in young adults and the elderly. Am J Med 1992 93 : 69 77.
31. Berg CM, Lissner L, Aires N et al. Trends in blood lipid levels, blood pressure, alcohol and smoking habits from 1985 to 2002: results from INTERGENE and GOT-MONICA. Eur J Cardiovasc Prev Rehabil 2005 12 : 115 25.
32. Hublet A, De Bacquer D, Valimaa R et al. Smoking trends among adolescents from 1990 to 2002 in ten European countries and Canada. BMC Public Health 2006 6 : 280.
33. Pugliatti M, Harbo HF, Holmøy T et al. Environmental risk factors in multiple sclerosis. Acta Neurol Scand 2008 117 (Suppl. 188 34 40.
34. Markowitz LE. Measles vaccine. In : Plotkin S, ed. Vaccines. Philadelphia, PA : Saunders, 1994 p. 229 76.
35. Wakefield AJ, Murch SH, Anthony A et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998 351 : 637 41.
36. Taylor B, Miller E, Farrington CP et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999 353 : 2026 9.
37. Madsen KM, Vestergaard M. MMR vaccination and autism: what is the evidence for a causal association? Drug Saf 2004 27 : 831 40.
38. Miller E, Gay N. Effect of age on outcome and epidemiology of infectious diseases. Biologicals 1997 25 : 137 42.